Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on offspring neurodevelopment: 5-year follow-up of a randomized controlled trial.

European journal of clinical nutrition·2017

Same author

A re-analysis of the 1968 Saltin et al. "Bedrest" paper.

Scandinavian journal of medicine & science in sports·2015

Same author

Sea-level haemoglobin concentration is associated with greater exercise capacity in Tibetan males at 4200 m.

Experimental physiology·2015

Same author

Low haemoglobin concentration in Tibetan males is associated with greater high-altitude exercise capacity.

The Journal of physiology·2015

Same author

Effects of lung ventilation-perfusion and muscle metabolism-perfusion heterogeneities on maximal O2 transport and utilization.

The Journal of physiology·2015

Same author

Incremental large and small muscle mass exercise in patients with heart failure: evidence of preserved peripheral haemodynamics and metabolism.

Acta physiologica (Oxford, England)·2014

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Possible mechanisms underlying the development of cachexia in COPD.

¹Division of Physiology, Dept of Medicine, University of California, San Diego, 9500 Gilman Drive, DEPT 0623A, La Jolla, CA 92093-0623A, USA. pdwagner@ucsd.edu

The European Respiratory Journal

|March 4, 2008

Summary

Chronic obstructive pulmonary disease (COPD) cachexia affects 25% of patients, significantly reducing survival. Its exact cause remains unclear, necessitating further research into its progression and underlying mechanisms.

Related Experiment Videos

Last Updated: Jul 7, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Area of Science:

Pulmonary Medicine
Metabolic Disorders
Cellular Biology

Background:

Cachexia affects approximately 25% of patients with chronic obstructive pulmonary disease (COPD).
This condition is linked to a substantial reduction in median survival.
Potential causes include energy imbalance, disuse atrophy, hypoxia, inflammation, and hormonal insufficiency.

Purpose of the Study:

To review the current understanding of cachexia pathogenesis in COPD.
To evaluate the effectiveness of existing therapeutic interventions.
To identify gaps in knowledge and suggest future research directions.

Main Methods:

Review of existing literature on COPD cachexia.
Analysis of proposed pathogenetic mechanisms.
Evaluation of data from therapeutic trials.

Main Results:

While genetic polymorphisms in inflammatory cytokines like IL-1beta are implicated, IL-6 and TNF-alpha do not show polymorphisms.
Recent studies question the role of elevated IL-6 and TNF-alpha levels in COPD cachexia.
Current therapeutic interventions show limited benefits in improving muscle structure and function.

Conclusions:

The precise cause of cachexia in COPD is not definitively established.
More mechanistic research is required before therapeutic recommendations can be made.
Future studies should adopt a prospective approach to observe cachexia progression, as inflammatory markers may normalize once cachexia is established.